Adis Drug Clinical Q&A

Drugs & Therapy Perspectives

, Volume 28, Issue 9, pp 1-4

First online:

Ulipristal acetate: a guide to its use in uterine fibroids

  • Katherine A. Lyseng-WilliamsonAffiliated withAdis Email author 
  • , Jamie D. CroxtallAffiliated withAdis

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Oral ulipristal acetate (Esmya™), a selective progesterone-receptor modulator, is an effective and well tolerated option for the pre-operative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age. It is associated with rapid control of excessive uterine bleeding and sustained reductions in uterine fibroid volume.